iShares Biotechnology ETF logo

iShares Biotechnology ETF (IBB)

Market Closed
7 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
128. 10
-1.9
-1.46%
$
8.81B Market Cap
0.5% Div Yield
184,867 Volume
$ 130
Previous Close
Day Range
127.13 129.69
Year Range
107.43 150.57
Want to track IBB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

IBB and XBI are similar in many ways, but their relative past performance does not tell the story. IBB is more concentrated, and that is ultimately why I prefer it to XBI. Both ETFs target a similar objective, and are over-diversified. For reasons I explain here.

Seekingalpha | 1 day ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 2 weeks ago
Should You Invest in the iShares Biotechnology ETF (IBB)?

Should You Invest in the iShares Biotechnology ETF (IBB)?

Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Zacks | 4 weeks ago
IBB: Now Is The Time To Be Contrarian

IBB: Now Is The Time To Be Contrarian

Biotech stocks have underperformed due to sector rotation, rising rates, and regulatory pressures, but I see a contrarian opportunity emerging. A close look at the recent performance of biotech stocks, the innovative pipeline, and AI-driven process improvements suggests the market may be missing the big picture. Institutional investors are getting back in on the action, evident from the strong Q1 in terms of deal activity.

Seekingalpha | 1 month ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.

Zacks | 2 months ago
Should You Invest in the iShares Biotechnology ETF (IBB)?

Should You Invest in the iShares Biotechnology ETF (IBB)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001.

Zacks | 3 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seekingalpha | 4 months ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 4 months ago
How tariffs could impact pharma and early-stage healthcare investments

How tariffs could impact pharma and early-stage healthcare investments

Carl Rizzuto, Versant Ventures managing director, joins 'Fast Money' to talk the impact of tariffs on healthcare.

Youtube | 5 months ago
Should You Invest in the iShares Biotechnology ETF (IBB)?

Should You Invest in the iShares Biotechnology ETF (IBB)?

Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Zacks | 5 months ago
I Was Convinced Biotech Stocks Were Too Risky—This Innovation's Changing the Game

I Was Convinced Biotech Stocks Were Too Risky—This Innovation's Changing the Game

The biotech scene can be seen as fairly risky for new investors who want to put money to work.

247wallst | 5 months ago
Why Biotech Sector ETF (IBB) May Turn Bullish In 2025

Why Biotech Sector ETF (IBB) May Turn Bullish In 2025

One of the big themes we see emerging into 2025 is an expansion in Biotechnology and a bullish backdrop for certain biotechnology stocks.

Seeitmarket | 6 months ago
Loading...
Load More